Australia is updating how pregnant women are tested for gestational diabetes, with new national guidelines released to improve diagnosis and care.
These changes, the first in over a decade, are expected to reduce unnecessary diagnoses among lower-risk women while focusing support on those who will benefit most. The update affects more than 280,000 pregnancies annually across the country.
What is Gestational Diabetes and Why Test for It?
Gestational diabetes mellitus (GDM) is a common pregnancy complication characterized by elevated blood sugar levels first detected during pregnancy. It affects nearly one in five Australian pregnancies. While GDM usually resolves after birth, women diagnosed are at least seven times more likely to develop type 2 diabetes later in life.
Routine screening for GDM remains recommended for all pregnant women because early detection and treatment reduce risks such as:
- Macrosomia (excessively large babies), which can complicate delivery
- Pre-eclampsia, a dangerous condition involving high blood pressure
- Other serious pregnancy complications
Screening also offers an opportunity to support women’s long-term health through nutrition and physical activity guidance.
Why Are Testing Practices Changing?
Although diagnosis and treatment benefit most women, some experience negative effects such as stigma, difficulty accessing specialized care, unhealthy dietary restrictions, or changes to their preferred birth plans. The new guidelines aim to balance the benefits of diagnosis with minimizing unnecessary interventions and stress.
Key Changes in Testing Protocols
Screening continues for all pregnant women without pre-existing diabetes between 24 and 28 weeks gestation using the oral glucose tolerance test (OGTT). This involves fasting, a sugary drink, and blood tests over two hours.
Early pregnancy screening (first trimester) will use a single, non-fasting HbA1c blood test for women with risk factors like high BMI or a history of large babies.
OGTT before 14 weeks will be reserved for women with significant risk factors such as previous gestational diabetes or elevated HbA1c.
Higher blood glucose thresholds will be used to diagnose GDM, reducing diagnoses in women with borderline results.
These adjustments allow healthcare providers to better allocate resources, ensuring women at higher risk receive timely support while reducing unnecessary interventions for others.
What Should Pregnant Women Do?
Women are encouraged to discuss these new guidelines with their maternity care providers to understand how the changes affect their individual care plans. Early engagement and personalized risk assessment will help optimize pregnancy outcomes.
Related topics:
